---
company: MICROCHIP TECHNOLOGY INC
ticker: MCHP
form: 8-K
filed: 2026-08-06
accession: 0000827054-26-000037
source: https://www.sec.gov/Archives/edgar/data/827054/000082705426000037/
---

# Microchip Technology (MCHP) earnings release, August 6, 2026

Microchip Technology Inc (MCHP) · Form 8-K, Item 2.02 · Filed 2026-08-06 · [SEC filing](https://www.sec.gov/Archives/edgar/data/827054/000082705426000037/)

MICROCHIP TECHNOLOGY ANNOUNCES FINANCIAL RESULTS FOR

FIRST QUARTER OF FISCAL YEAR 2027

• Net sales of $1.485 billion, increased

38.0% from the year-ago quarter and up 13.2% sequentially. The midpoint of our guidance provided on May 7, 2026 was net sales of $1.456 billion.

• On a GAAP basis: gross profit of 63.2%; operating income of $336.8 million and 22.7% of net sales; net income attributable to common stockholders of $202.0 million; and EPS of $0.37 per diluted share. Our guidance provided on May 7, 2026 was GAAP EPS per diluted share of $0.28 to $0.29.

• On a Non-GAAP basis: gross profit of 63.8%; operating income of $521.1 million and 35.1% of net sales; net income of $438.6 million; and EPS of $0.76 per diluted share. Our guidance provided on May 7, 2026 was Non-GAAP EPS per diluted share of $0.67 to $0.71.

• Returned approximately $246.9 million to common stockholders in the June quarter through dividends.

• Quarterly dividend on common stock declared for the September quarter of 45.5 cents per share.

• Continued balance sheet deleveraging with approximately $170 million reduction in net debt during the June quarter.

CHANDLER, Arizona - August 6, 2026 - (NASDAQ: MCHP)

- Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today reported results for the three months ended June 30, 2026.

"We kicked off fiscal 2027 on a strong note, with net sales increasing 38% year over year and 13.2% sequentially to $1.485 billion, above the high end of our guidance," said Steve Sanghi, Microchip’s President and Chief Executive Officer. "Improving demand, continued inventory normalization, and stronger factory utilization contributed to better operational leverage during the quarter and support our continued progress towards our long-term business model."

- - more - -

Microchip Technology Incorporated 2355 West Chandler Blvd. Chandler, AZ 85224-6199 Main Office 480•792•7200

Microchip Technology Reports

First Quarter Fiscal 2027

Financial Results

Page 2

Mr. Sanghi added, “Our operational metrics strengthened during the quarter, with inventory days declining from 185 days on March 31 to 175 days on June 30 and non-GAAP gross margin expanding sequentially to 63.8%, above the high end of our guidance range. Distribution sell-through increased meaningfully, bookings remained strong with a book-to-bill ratio well above 1, and customer activity improved across several key end markets. We also saw PCIe Gen6 connectivity design wins double sequentially from six programs at the end of the March quarter to 12 programs exiting the June quarter, reflecting growing momentum in data center and connectivity applications. Taken together, these trends reinforce our confidence in both the recovery underway and our long-term growth opportunities.”

Eric Bjornholt, Microchip's Corporate Senior Vice President and Chief Financial Officer, said, "Our June quarter financial performance demonstrates the strength of our operating model and the significant leverage embedded in the business as revenue recovers. Higher factory utilization, lower underutilization charges, and disciplined expense management drove meaningful sequential improvements in profitability and cash generation during the quarter. We also continued to strengthen our balance sheet and improve financial flexibility by reducing net debt by approximately $170 million during the quarter.”

Mr. Sanghi concluded, “As we enter the September quarter, improving demand trends, healthy bookings activity, stronger customer engagement, and increasing traction in growth-oriented applications continue to reinforce our confidence in the direction of the business. We expect net sales for the September quarter to be up sequentially between 7% and 9%, which at the midpoint would represent year-over-year growth of approximately 40.6%. Improving factory utilization and operational leverage are expected to support further progress toward our long-term margin objectives.”

- - more - -

Microchip Technology Reports

First Quarter Fiscal 2027

Financial Results

Page 3

The following table summarizes Microchip's reported results for the three months ended June 30, 2026.

(1)

In millions, except per share amounts and percentages of net sales.

(2)

See the "Use of Non-GAAP Financial Measures" section of this release.

Net sales for the first quarter of fiscal 2027 were $1.485 billion, up 38.0% from net sales of $1.076 billion in the prior year's first fiscal quarter.

GAAP net income attributable to common stockholders for the first quarter of fiscal 2027 was $202.0 million, or $0.37 per diluted share, up from GAAP net loss attributable to common stockholders of $46.4 million, or $0.09 per diluted share, in the prior year's first fiscal quarter. For the first quarters of fiscal 2027 and fiscal 2026, GAAP results were adversely impacted by amortization of acquired intangible assets associated with our previous acquisitions.... (truncated) our non-GAAP and GAAP results is included in this press release.

Microchip announced today that its Board of Directors declared a quarterly cash dividend on its common stock of 45.5 cents per share, which is payable on September 9, 2026 to stockholders of record on August 24, 2026.

The Microchip Board also declared a quarterly cash dividend on Microchip's

7.50%

Series A Mandatory Convertible Preferred Stock of

$18.750 per share (which represents

$0.9375 per depositary share) which is payable on

September 15, 2026 to stockholders of record on

September 1, 2026.

- - more - -

Microchip Technology Reports

First Quarter Fiscal 2027

Financial Results

Page 4

Second Quarter Fiscal Year 2027 Outlook:

The following statements are based on current expectations. These statements are forward-looking, and actual results may differ materially.

(1)

See the "Use of Non-GAAP Financial Measures" section of this release for information regarding our non-GAAP guidance.

(2)

We are not able to estimate the amount of certain Special Charges and Other, net that may be incurred during the quarter ending September 30, 2026. Therefore, our estimate of GAAP operating expenses excludes certain amounts that may be recognized as Special Charges and Other, net in the quarter ending September 30, 2026.

(3)

The forecast for GAAP tax expense excludes any unexpected tax events that may occur during the quarter, as these amounts cannot be forecasted.

(4)

Represents the expected cash tax rate for fiscal 2027, excluding any transition tax payments associated with the Tax Cuts and Jobs Act.

(5)

Our GAAP guidance excludes the impact of any potential gains or charges related to our ongoing evaluation of restructuring activities including the sale of our Fab 2 wafer fabrication facility in Tempe, Arizona.

Capital expenditures for the quarter ending September 30, 2026 are expected to be between $20 million and $25 million. Capital expenditures for all of fiscal 2027 are expected to be approximately $100 million. Consistent with the slow macroeconomic environment in fiscal 2025, we have paused most of our factory expansion actions and reduced our planned capital investments through fiscal 2027. However, we are adding capital equipment to selectively expand our production capacity and add research and development equipment.

Under the GAAP revenue recognition standard, we are required to recognize revenue when control of the product changes from us to a customer or distributor. We focus our sales and marketing efforts on creating demand for our products in the end markets we serve and not on moving inventory into our distribution network. We also manage our manufacturing and supply chain operations, including our distributor relationships, towards the goal of having our products available at the time and location the end customer desires.

- - more - -

Microchip Technology Reports

First Quarter Fiscal 2027

Financial Results

Page 5

Use of Non-GAAP Financial Measures:

Our non-GAAP adjustments, where applicable, include the effect of share-based compensation, restructuring charges, expenses related to our acquisition activities (including intangible asset amortization, severance, other restructuring costs, and legal and other general and administrative expenses including legal fees and expenses for litigation related to our Microsemi acquisition), professional services associated with certain legal matters, and dividends on our Series A Mandatory Convertible Preferred Stock. For the first quarters of fiscal 2027 and fiscal 2026, our non-GAAP income tax expense is presented based on projected cash taxes for the fiscal year, excluding transition tax payments under the Tax Cuts and Jobs Act.

We are required to estimate the cost of certain forms of share-based compensation, including restricted stock units and our employee stock purchase plan, and to record a commensurate expense in our income statement. Share-based compensation expense is a non-cash expense that varies in amount from period to period and is affected by the price of our stock at the date of grant. The price of our stock is affected by market forces that are difficult to predict and are not within the control of management. Our other non-GAAP adjustments are either non-cash expenses, unusual or infrequent items, or other expenses related to transactions. Management excludes all of these items from its internal operating forecasts and models.

We are using non-GAAP operating expenses in dollars, including non-GAAP research and development expenses and non-GAAP selling, general and administrative expenses, non-GAAP other expense, net, and non-GAAP income tax rate, which exclude the items noted above, as applicable, to permit additional analysis of our performance.

Management believes these non-GAAP measures are useful to investors because they enhance the understanding of our historical financial performance and comparability between periods. Many of our investors have requested that we disclose this non-GAAP information because they believe it is useful in understanding our performance as it excludes non-cash and other charges that many investors feel may obscure our underlying operating results. Management uses non-GAAP measures to manage and assess the profitability of our business and for compensation purposes. We also use our non-GAAP results when developing and monitoring our budgets and spending. Our determination of these non-GAAP measures might not be the same as similarly titled measures used by other companies, and it should not be construed as a substitute for amounts determined in accordance with GAAP. There are limitations associated with using these non-GAAP measures, including that they exclude financial information that some may consider important in evaluating our performance. Management compensates for this by presenting information on both a GAAP and non-GAAP basis for investors and providing reconciliations of the GAAP and non-GAAP results.

Generally, gross profit fluctuates over time, driven primarily by the mix of products sold and licensing revenue; variances in manufacturing yields; fixed cost absorption; wafer fab loading levels; costs of wafers from foundries; inventory reserves; pricing pressures in our non-proprietary product lines; and competitive and economic conditions. Operating expenses fluctuate over time, primarily due to net sales and profit levels.

- - more - -

Microchip Technology Reports

First Quarter Fiscal 2027

Financial Results

Page 6

Diluted Common Shares Outstanding can vary for, among other things, the trading price of our common stock, the vesting of restricted stock units, the potential for incremental dilutive shares from our convertible debentures and our mandatory convertible preferred stock (additional information regarding our share count is available in the investor relations section of our website under the heading "Supplemental Information"), and repurchases or issuances of shares of our common stock. The diluted common shares outstanding presented in the guidance table above assumes an average Microchip stock price in the September 2026 quarter between $75 and $85 per share (however, we make no prediction as to what our actual share price will be for such period or any other period).

- - more - -

Page 7

## Financial statements

### Income Statement (The following table summarizes Microchip's reported results for the three months ended June 30, 2026.)

| | Three Months Ended June 30, 2026(1) | GAAP | % | Non-GAAP(2) | % |
|---|---:|---:|---:|---:|---:|
| Net sales | 1,484.7 |  |  |  |  |
| Gross profit |  | 938.9 | 63.2% | 947.6 | 63.8% |
| Operating income |  | 336.8 | 22.7% | 521.1 | 35.1% |
| Other expense |  | -46.9 |  | -46.9 |  |
| Income tax provision |  | 60.1 |  | 35.6 |  |
| Net income |  | 229.8 |  | 438.6 |  |
| Dividends on Series A Preferred Stock |  | -27.8 |  |  |  |
| Net income attributable to common stockholders |  | 202 | 13.6% | 438.6 | 29.5% |
| Diluted net income per common share |  | 0.37 |  | 0.76 |  |

### Income Statement (The following statements are based on current expectations. These statements are forward-looking, and actual results may differ materially.)

| | Microchip Consolidated Guidance | GAAP(5) | Non-GAAP Adjustments(1) | Non-GAAP(1) |
|---|---:|---:|---:|---:|
| Net Sales | $1.589 to $1.618 billion |  |  |  |
| Gross Profit |  | 65.4% to 66.3% | $10.3 to $11.3 million | 66.0% to 67.0% |
| Operating Expenses(2) |  | 37.3% to 37.4% | $155.7 to $159.7 million | 27.5% |
| Operating Income |  | 28.1% to 28.9% | $166.0 to $171.0 million | 38.5% to 39.5% |
| Other Expense, net |  | $48.7 to $49.3 million | $(0.2) to $0.2 million | $48.5 to $49.5 million |
| Income Tax Provision |  | $75.3 to $96.5 million(3) | $(52.2) to $(33.1) million | $42.2 to $44.3 million(4) |
| Net income |  | $321.0 to $323.0 million | $199.0 to $223.4 million | $520.0 to $546.4 million |
| Dividends on Series A Preferred Stock |  | $(27.8) million | $27.8 million |  |
| Net income attributable to common stockholders |  | $293.2 to $295.2 million | $226.8 to $251.2 million | $520.0 to $546.4 million |
| Diluted Common Shares Outstanding |  | Approximately 550.7 to 551.7 million shares | 23.8 million shares | Approximately 574.5 to 575.5 million shares |
| Diluted net income per common share |  | $0.53 to $0.54 | $0.38 to $0.41 | $0.91 to $0.95 |

### Income Statement (Three Months Ended June 30, — (in millions, except per share amounts, unaudited))

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 |
|---|---:|---:|
| Net sales | 1,484.7 | 1,075.5 |
| Cost of sales | 545.8 | 498.8 |
| Gross profit | 938.9 | 576.7 |
| Research and development | 308.9 | 255.5 |
| Selling, general and administrative | 184.3 | 159.3 |
| Amortization of acquired intangible assets | 90 | 107.6 |
| Special charges and other, net | 18.9 | 22.2 |
| Operating expenses | 602.1 | 544.6 |
| Operating income | 336.8 | 32.1 |
| Other expense, net | -46.9 | -47.9 |
| Income (loss) before income taxes | 289.9 | -15.8 |
| Income tax provision | 60.1 | 2.8 |
| Net income (loss) | 229.8 | -18.6 |
| Dividends on Series A Preferred Stock | -27.8 | -27.8 |
| Net income (loss) attributable to common stockholders | 202 | -46.4 |
| Basic net income (loss) per common share | 0.37 | -0.09 |
| Diluted net income (loss) per common share | 0.37 | -0.09 |
| Basic common shares outstanding | 542.5 | 539.2 |
| Diluted common shares outstanding | 550.5 | 539.2 |

### Income Statement (Three Months Ended June 30, — RECONCILIATION OF GAAP GROSS PROFIT TO NON-GAAP GROSS PROFIT)

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 |
|---|---:|---:|
| Gross profit, as reported | 938.9 | 576.7 |
| Share-based compensation expense | 8.7 | 7.7 |
| Non-GAAP gross profit | 947.6 | 584.4 |
| GAAP gross profit percentage | 63.2 | 53.6 |
| Non-GAAP gross profit percentage | 63.8 | 54.3 |

### Income Statement (Three Months Ended June 30, — RECONCILIATION OF GAAP SELLING, GENERAL AND ADMINISTRATIVE EXPENSES TO NON-GAAP SELLING, GENERAL AND ADMINISTRATIVE EXPENSES)

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 |
|---|---:|---:|
| Selling, general and administrative expenses, as reported | 184.3 | 159.3 |
| Share-based compensation expense | -25.2 | -16.1 |
| Professional services associated with certain legal matters | -0.4 | -7.5 |
| Non-GAAP selling, general and administrative expenses | 158.7 | 135.7 |
| GAAP selling, general and administrative expenses as a percentage of net sales | 12.4 | 14.8 |
| Non-GAAP selling, general and administrative expenses as a percentage of net sales | 10.7 | 12.6 |

### Income Statement (Three Months Ended June 30, — RECONCILIATION OF GAAP OPERATING EXPENSES TO NON-GAAP OPERATING EXPENSES)

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 |
|---|---:|---:|
| Operating expenses, as reported | 602.1 | 544.6 |
| Share-based compensation expense | -66.3 | -45.2 |
| Professional services associated with certain legal matters | -0.4 | -7.5 |
| Amortization of acquired intangible assets (1) | -90 | -107.6 |
| Special charges and other, net | -18.9 | -22.2 |
| Non-GAAP operating expenses | 426.5 | 362.1 |
| GAAP operating expenses as a percentage of net sales | 40.6 | 50.6 |
| Non-GAAP operating expenses as a percentage of net sales | 28.7 | 33.7 |

### Income Statement (Three Months Ended June 30, — RECONCILIATION OF GAAP OPERATING INCOME TO NON-GAAP OPERATING INCOME)

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 |
|---|---:|---:|
| Operating income, as reported | 336.8 | 32.1 |
| Share-based compensation expense | 75 | 52.9 |
| Professional services associated with certain legal matters | 0.4 | 7.5 |
| Amortization of acquired intangible assets (1) | 90 | 107.6 |
| Special charges and other, net | 18.9 | 22.2 |
| Non-GAAP operating income | 521.1 | 222.3 |
| GAAP operating income as a percentage of net sales | 22.7 | 3 |
| Non-GAAP operating income as a percentage of net sales | 35.1 | 20.7 |

### Income Statement (Three Months Ended June 30,)

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 |
|---|---:|---:|
| Net income (loss) attributable to common stockholders, as reported | 202 | -46.4 |
| Dividends on Series A Preferred Stock | 27.8 | 27.8 |
| Share-based compensation expense | 75 | 52.9 |
| Professional services associated with certain legal matters | 0.4 | 7.5 |
| Amortization of acquired intangible assets | 90 | 107.6 |
| Special charges and other, net | 18.9 | 22.2 |
| Other non-GAAP tax adjustment | 24.5 | -16.9 |
| Non-GAAP net income | 438.6 | 154.7 |

### Balance Sheet ((in millions, unaudited))

| | ASSETS – June 30, – 2026 | ASSETS – March 31, – 2026 |
|---|---:|---:|
| Cash and short-term investments | 272.3 | 240.3 |
| Accounts receivable, net | 967.7 | 894.7 |
| Inventories | 1,047.3 | 1,035.4 |
| Other current assets | 198.9 | 207.2 |
| Total current assets | 2,486.2 | 2,377.6 |
| Property, plant and equipment, net | 1,084.4 | 1,106.7 |
| Other assets | 10,836.8 | 10,885.8 |
| Total assets | 14,407.4 | 14,370.1 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | Accounts payable and accrued liabilities | 1,294.4 | 1,136.3 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | Total current liabilities | 1,294.4 | 1,136.3 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | Long-term debt | 5,361.3 | 5,496.4 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | Long-term income tax payable | 580.2 | 570.9 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | Long-term deferred tax liability | 25.4 | 25.1 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | Other long-term liabilities | 695.1 | 709 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | Stockholders' equity | 6,451 | 6,432.4 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | Total liabilities and stockholders' equity | 14,407.4 | 14,370.1 |
